药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Cirazoline
The risk or severity of hypertension can be increased when Cannabidiol is combined with Cirazoline.
Potassium cation
Benzydamine
The risk or severity of hypertension can be increased when Cannabidiol is combined with Benzydamine.
Potassium cation
Epirizole
The risk or severity of hypertension can be increased when Epirizole is combined with Cannabidiol.
Potassium cation
Etofenamate
The risk or severity of hypertension can be increased when Etofenamate is combined with Cannabidiol.
Potassium cation
Fenbufen
The risk or severity of hypertension can be increased when Fenbufen is combined with Cannabidiol.
Potassium cation
Floctafenine
The risk or severity of hypertension can be increased when Floctafenine is combined with Cannabidiol.
Potassium cation
Hexoprenaline
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Cannabidiol.
Potassium cation
Ibuproxam
The risk or severity of hypertension can be increased when Ibuproxam is combined with Cannabidiol.
Potassium cation
Indoprofen
The risk or severity of hypertension can be increased when Indoprofen is combined with Cannabidiol.
Potassium cation
Indoramin
The risk or severity of hypertension can be increased when Indoramin is combined with Cannabidiol.
Potassium cation
Isoxicam
The risk or severity of hypertension can be increased when Isoxicam is combined with Cannabidiol.
Potassium cation
Kebuzone
The risk or severity of hypertension can be increased when Kebuzone is combined with Cannabidiol.
Potassium cation
Adrafinil
The risk or severity of hypertension can be increased when Adrafinil is combined with Cannabidiol.
Potassium cation
Salicylamide
The risk or severity of hypertension can be increased when Salicylamide is combined with Cannabidiol.
Potassium cation
Azapropazone
The risk or severity of hypertension can be increased when Azapropazone is combined with Cannabidiol.
Potassium cation
Saralasin
The risk or severity of hypertension can be increased when Saralasin is combined with Cannabidiol.
Potassium cation
Naphazoline
The risk or severity of hypertension can be increased when Naphazoline is combined with Cannabidiol.
Potassium cation
Levonordefrin
The risk or severity of hypertension can be increased when Levonordefrin is combined with Cannabidiol.
Potassium cation
Isometheptene
The risk or severity of hypertension can be increased when Isometheptene is combined with Cannabidiol.
Potassium cation
Xylometazoline
The risk or severity of hypertension can be increased when Xylometazoline is combined with Cannabidiol.